Archives

  • 2026-08
  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • Influenza Hemagglutinin (HA) Peptide: Precision Tag for P...

    2026-01-24

    Harnessing the Influenza Hemagglutinin (HA) Peptide for Advanced Protein Purification and Interaction Studies

    Principle and Setup: The Influenza Hemagglutinin (HA) Peptide as a Molecular Biology Workhorse

    The Influenza Hemagglutinin (HA) Peptide (SKU: A6004) is a synthetic nine-amino acid sequence (YPYDVPDYA) derived from the epitope region of the human influenza hemagglutinin protein. Functioning as an epitope tag for protein detection, this HA tag peptide is designed to facilitate the detection, purification, and elution of HA-tagged fusion proteins. Its utility is rooted in its high specificity for anti-HA antibodies, enabling competitive binding and efficient elution of target proteins during immunoprecipitation with anti-HA antibody workflows.

    With a purity exceeding 98% (confirmed by HPLC and mass spectrometry), and exceptional solubility (≥55.1 mg/mL in DMSO, ≥100.4 mg/mL in ethanol, and ≥46.2 mg/mL in water), the HA peptide from APExBIO is engineered to suit a wide spectrum of experimental buffers and conditions. Its high solubility ensures reproducible results across diverse protein purification tag applications, minimizing aggregation or precipitation issues that can hinder downstream analyses. The hemagglutinin tag is also invaluable in protein-protein interaction studies, as its compatibility with various detection and purification platforms offers scientists the flexibility needed for both routine and advanced molecular biology workflows.

    Step-by-Step Workflow: Enhanced Protocols for Immunoprecipitation and Elution

    1. Construct Design and Expression

    Begin by cloning your gene of interest into an expression vector containing the HA tag DNA sequence, ensuring that the HA tag (YPYDVPDYA) is positioned such that it will be accessible after translation. Confirm the integrity of the construct and sequence, paying attention to the ha tag nucleotide sequence to avoid frame shifts or unintended mutations.

    2. Expression and Lysis

    Express the HA-tagged protein in your system of choice (e.g., mammalian, yeast, or bacterial cells). Lyse cells using an appropriate buffer, incorporating protease inhibitors to maintain protein integrity. The high solubility of the Influenza Hemagglutinin (HA) Peptide ensures minimal loss during lysis and preparation.

    3. Immunoprecipitation

    For immunoprecipitation with anti-HA antibody, incubate the lysate with anti-HA magnetic beads or resin-conjugated antibodies. The beads will specifically bind HA-tagged proteins, forming a stable complex. After incubation, wash the beads thoroughly to remove non-specifically bound proteins. The HA tag peptide ensures reliable capture, supporting both high- and low-abundance protein targets.

    4. Competitive Elution with HA Peptide

    Add the HA fusion protein elution peptide (typically at 0.5–1 mg/mL, but optimization is advised) to the bead-protein complex. The Influenza Hemagglutinin epitope sequence will competitively bind to the anti-HA antibody, displacing your HA-tagged protein. Incubate for 30–60 minutes at 4°C with gentle agitation. Collect the supernatant, which now contains the purified HA fusion protein. The process maintains native conformation and post-translational modifications, which is critical for downstream protein-protein interaction studies.

    5. Analysis and Validation

    Analyze the eluted protein via SDS-PAGE, Western blotting (using anti-HA or target-specific antibodies), or mass spectrometry. The HA peptide’s specificity minimizes background, facilitating clear signal detection and quantification.

    Advanced Applications and Comparative Advantages

    APExBIO’s Influenza Hemagglutinin (HA) Peptide demonstrates significant advantages over conventional tags (such as FLAG, Myc, or His), particularly in applications requiring high sensitivity, efficient competitive elution, and minimal off-target effects. Its unmatched solubility enables the preparation of concentrated peptide stocks suitable for high-throughput workflows or challenging experimental setups. This is particularly valuable in translational cancer biology, where sensitivity and specificity are paramount.

    For example, a recent study (Dong et al., 2025) investigating the role of E3 ligase NEDD4L in colorectal cancer liver metastasis relied on precise detection and characterization of HA-tagged protein complexes. The researchers utilized HA tag peptide-based immunoprecipitation to elucidate the interaction between NEDD4L and its substrate PRMT5, a process that depends on robust, reproducible capture and elution—capabilities that the HA peptide supports exceptionally well.

    This application is echoed in industry reviews, such as the LabPE article, which highlights the peptide’s precision in advanced molecular workflows. Similarly, Magnetic Co-IP contrasts the HA tag with alternatives, noting its ultrasensitive detection and compatibility with various buffer conditions, while GTP-Binding Protein Fragment G Alpha extends the discussion, providing actionable guidance for enhancing reproducibility and workflow efficiency with SKU A6004.

    Moreover, the HA tag sequence is short and minimally immunogenic, reducing potential interference with protein function or localization. Its well-characterized ha peptide and ha tag sequence make it an optimal choice for protein-protein interaction studies, especially in the context of ubiquitination research and mechanistic enzymology, as evidenced by its role in studies of E3 ligases and post-translational regulation.

    Troubleshooting and Optimization Tips

    • Peptide Solubility Issues: If the HA peptide appears insoluble, prepare it first in DMSO or ethanol before diluting into aqueous buffers. The peptide’s solubility values (≥55.1 mg/mL in DMSO, ≥100.4 mg/mL in ethanol, and ≥46.2 mg/mL in water) support this approach.
    • Low Recovery During Elution: Optimize the concentration of the elution peptide. Starting at 0.5 mg/mL and titrating upwards can improve elution efficiency for tightly bound HA-tagged proteins.
    • High Background or Non-specific Binding: Ensure thorough washing steps and consider pre-clearing lysates with control beads. Using high-purity HA peptide (>98%) from APExBIO ensures minimal contaminants that could contribute to background.
    • Loss of Protein Activity: Use mild elution conditions (e.g., 4°C, neutral pH) to preserve native structure and function, particularly essential in protein-protein interaction studies.
    • Storage and Stability: Store the lyophilized peptide desiccated at -20°C. Avoid long-term storage of peptide solutions; prepare fresh solutions as needed for maximum performance.
    • Buffer Compatibility: The HA peptide’s compatibility with a range of buffers allows adaptation to specific assay requirements (e.g., high salt, detergent, or reducing conditions), but always confirm peptide solubility in the chosen buffer before large-scale experiments.

    For further troubleshooting, the GTP-Binding Protein Fragment G Alpha article provides scenario-driven Q&As that complement the workflow recommendations above, helping researchers navigate common pitfalls and optimize their protocols.

    Future Outlook: Expanding the Frontiers of Protein Tagging and Translational Research

    The Influenza Hemagglutinin (HA) Peptide continues to evolve as a gold-standard molecular biology peptide tag. Its role is expanding beyond traditional immunoprecipitation applications to encompass high-throughput screening, exosome isolation, and multiplexed detection in complex biological matrices. As next-generation proteomics and functional genomics demand even greater precision, the HA tag’s minimal sequence, robust specificity, and competitive binding to anti-HA antibody ensure its continued relevance.

    With the growing interest in ubiquitin-mediated regulation in cancer and other diseases—as illustrated in the referenced NEDD4L-PRMT5 study—the HA peptide is poised to remain central in dissecting dynamic protein networks. Its integration with high-sensitivity detection platforms and automated liquid handling systems will further streamline protein purification and interaction studies.

    In summary, the Influenza Hemagglutinin (HA) Peptide from APExBIO empowers researchers with a reliable, high-purity, and versatile tool for advancing molecular and translational science. By leveraging its unique properties and integrating best-practice troubleshooting, scientists can confidently interrogate protein complexes, refine purification workflows, and accelerate the discovery of new biological mechanisms.